The New York Times reports.

In South Carolina, for example, legislators still don’t agree on a bill needing a 24-hour wait before a female could possess an abortion, The Associated Press/Spartanburg Herald-Journal reports. A committee of Home and Senate members attempted again Wednesday morning hours to hash out variations in the versions each chamber passed. But, as in previous tries, no progress was made. The bill’s likelihood of passing this year are dwindling. The standard session is to end Thursday . This article is certainly republished with kind permission from our friends at The Kaiser Family Foundation. You will see the complete Kaiser Daily Health Policy Survey, search the archives, or join email delivery of in-depth coverage of wellness policy developments, debates and discussions.The data confirms previous analysis which reported that among ovarian tumor patients of Ashkenazi-Jewish heritage, BRCA1/2 mutations are linked improved long-term survival. For this study, researchers examined 85 advanced-stage ovarian cancer patients with non-AJ BRCA mutations and 116 individuals who didn’t express any type of BRCA mutation. In comparison to patients without BRCA mutations, non-AJ BRCA carriers got much longer progression-free survival of 19.0 vs. 27.8 months and improved overall survival of 65.6 vs. 101.4 months. Non-AJ BRCA sufferers had a 2.15 times greater probability of complete response to initial chemotherapy response over sporadic, non-carrier patients.